Randomized Control Trial (RCT) of Early Palliative Care for HCC

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The purpose of this research study is to evaluate the effect of early palliative care consultation on quality of life, use of hospital resources, end-of-life care and survival among Hepatocellular Carcinoma (HCC) patients with advanced End Stage Live Disease not eligible for potentially curative or local area therapy. Half of patients will receive early palliative care at diagnosis of HCC and other half will receive palliative care when all standard therapy treatments have been exhausted.
Epistemonikos ID: d0ebc07bbbe26bf2ba274d2b0d5a007f8ddb316b
First added on: May 12, 2024